Pallas Health vs Enhance MD: Brand Options vs Low Intro Price
Quick verdict: Pallas Health is best if you want a clinician to choose between FDA-approved pens and a per-patient compounded preparation; Enhance MD is best if your priority is the lowest first-month compounded price and a flat-rate cost that does not rise with dose. This article compares Pallas Health vs Enhance MD across pricing, drug options, pricing model, telehealth format, and shipping and volume claims so you can decide which tradeoffs matter.
See Pallas Health plans and clinician options
Pallas Health vs Enhance MD at a glance
This direct comparison uses only published provider details. The three most distinctive differences are: Pallas offers branded FDA-approved GLP-1 options plus compounded fills; Enhance MD advertises the lowest first-month compound prices; and pricing structure differs, with Enhance MD using flat-rate pricing while Pallas prices compounded plans by medication with 12-week renewal periods.
Comparison table
| Criteria | Pallas Health | Enhance MD |
|---|---|---|
| Starting price (semaglutide) | $139 first month for compounded semaglutide | $49 first month for semaglutide |
| Ongoing pricing | Compounded semaglutide $597 every 12 weeks (about $199/mo avg); compounded tirzepatide $897 every 12 weeks (about $299/mo avg); brand-name cash prices listed | Flat-rate ongoing pricing applies after intro; ongoing rate stays the same at every dose (published ongoing rates vary) |
| Branded medications | Offers FDA-approved Wegovy, Ozempic, Zepbound and Mounjaro plus compounded options | Compounded medications only; no branded Ozempic or Wegovy listed |
| Pricing model | Compounded plans priced by medication rather than milligram so titration does not raise plan price; intro month differs from renewal cadence | Same price at every dose; no fee escalation during titration once ongoing rate is set |
| Telehealth and intake | 100% online; US-licensed clinician review; asynchronous in most states (43 of 50 need no video visit); some states require video | Clinician-directed telehealth platform; treated over 10,000 patients; treatment available when a licensed clinician determines it is medically appropriate |
| Shipping and extras | Free expedited and discreet shipping on every plan; compounded in the USA | Promotions noted such as up to $150 off first order; specifics vary by landing page |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
Pricing detail and payment structure
Pallas Health publishes a clear first-month figure for compounded semaglutide of $139, then a renewal cadence of $597 every 12 weeks (roughly $199 per month average). Compounded tirzepatide starts at $179 then renews $897 every 12 weeks (about $299 per month average). Pallas also lists cash-pay prices for branded GLP-1s by month. Enhance MD emphasizes the lowest first-month prices in the market with semaglutide from $49 and tirzepatide from $99, and highlights flat-rate pricing where the ongoing price remains the same regardless of dose after the introductory period.
Check Enhance MD introductory pricing
Drug options and clinical routing
Pallas Health explicitly offers both FDA-approved brand-name GLP-1 options and clinician-personalized compounded semaglutide or tirzepatide prepared in the USA when a brand medication is not the right fit. Enhance MD provides compounded semaglutide and tirzepatide only. Both providers note that treatment is available only when a licensed clinician determines it is medically appropriate and both include the regulatory qualifier that compounded medications are not FDA-approved.
Telehealth access, patient volume, and operational notes
Pallas markets itself as 100% online with asynchronous care in most states, stating that 43 of 50 states need no video visit while seven states plus Washington D.C. require a video visit. Enhance MD highlights a large real-world volume, saying it has treated more than 10,000 patients, and notes clinician-directed compounds and metabolic lab testing cadence in its materials. Pallas includes provider care, check-ins and messaging in its plan price with no membership fee; Enhance MD emphasizes predictable budgeting through flat-rate pricing.
Compare Pallas Health clinician review and plan details
Shipping, promotions, and consumer considerations
Pallas states free expedited and discreet shipping on every plan and that compounded medications are prepared by US-licensed compounding pharmacies. Enhance MD mentions promotional savings such as up to $150 off a first order and positions its introductory prices as market-leading for the first month. Neither provider bills insurance according to the published material; both operate on cash-pay models and note that compounded medications are not FDA-approved.
Start Pallas Health intake and see brand vs compound choices
How to choose between Pallas Health vs Enhance MD
Choose Pallas Health if you want a clinician to consider FDA-approved brand-name pens such as Wegovy or Ozempic as well as US-compounded semaglutide or tirzepatide, if you value free expedited shipping, or if you prefer a plan that includes provider care, check-ins and messaging with no membership fee. Choose Enhance MD if your top priority is the lowest first-month compounded price for semaglutide or tirzepatide and a flat-rate ongoing pricing approach that does not increase as dose rises. Both providers require clinician review and both note that compounded medications are not FDA-approved.
Primary keyword near conclusion: Pallas Health vs Enhance MD is primarily a tradeoff between branded options and clinician choice at Pallas and the lowest introductory compounded prices and flat-rate budget certainty at Enhance MD. Use the table and the guidance above to match your priorities to the provider features offered.